Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shandong Pharmaceutical Glass Co's quarterly Total Liabilities
increased
from Sep. 2025 (¥1,733.28 Mil) to Dec. 2025 (¥1,749.13 Mil) and
increased
from Dec. 2025 (¥1,749.13 Mil) to Mar. 2026 (¥1,760.28 Mil).
Shandong Pharmaceutical Glass Co's annual Total Liabilities
increased
from Dec. 2023 (¥1,784.21 Mil) to Dec. 2024 (¥2,132.24 Mil) but then
declined
from Dec. 2024 (¥2,132.24 Mil) to Dec. 2025 (¥1,749.13 Mil).
Shandong Pharmaceutical Glass Co Total Liabilities Related Terms
Shandong Pharmaceutical Glass Co Total Liabilities Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Pharmaceutical Glass Co Total Liabilities Chart
Shandong Pharmaceutical Glass Co Total Liabilities Calculation
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Pharmaceutical Glass Co (SHSE:600529) has a Total Liabilities of ¥1,760 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Shandong Pharmaceutical Glass Co and its competitors.
Is Shandong Pharmaceutical Glass Co's Total Liabilities too high?
Shandong Pharmaceutical Glass Co's current Total Liabilities is ¥1,760 Mil. Overall, Shandong Pharmaceutical Glass Co has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Pharmaceutical Glass Co's Total Liabilities compare to SW and PKG?
Shandong Pharmaceutical Glass Co's Total Liabilities of ¥1,760 Mil can be compared against companies in the Packaging & Containers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Packaging & Containers company?
A good Total Liabilities depends on the Packaging & Containers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Shandong Pharmaceutical Glass Co and its competitors. Shandong Pharmaceutical Glass Co's current Total Liabilities is ¥1,760 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Pharmaceutical Glass Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co (SHSE:600529) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥24.29, compared to a current price of ¥19.04 — trading 21.6% below its estimated fair value. The current Total Liabilities is ¥1,760 Mil. Shandong Pharmaceutical Glass Co's overall GF Score™ is 90/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Shandong Pharmaceutical Glass Co (SHSE:600529), the current Total Liabilities is ¥1,760 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Pharmaceutical Glass Co (SHSE:600529) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co stock appears to be undervalued.
The current stock price of ¥19.04 is trading 21.6% below its estimated GF Value™ of ¥24.29.
GuruFocus considers Shandong Pharmaceutical Glass Co to be Modestly Undervalued.
Key valuation signals for SHSE:600529:
Total Liabilities: ¥1,760 Mil
GF Value™: ¥24.29 vs. price of ¥19.04 (21.6% below fair value)
No single metric tells the full story. See the SHSE:600529 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Pharmaceutical Glass Co Business Description
Shandong Pharmaceutical Glass Co Ltd is a pharmaceutical glass packaging product company. Its pharmaceutical glass packaging products and butyl rubber series products which service object of pharmaceutical, food, daily necessities industries. The products include for moulded injection vial for antibiotics series, tubular glass vial series, amber glass bottle series, neutral borosilicate glass bottle series, infusion bottle series, cosmetic bottles series, food bottles series, butyl rubber stopper series, prefillable syringes series, and aluminum-plastic cap series.
90GF Score
Get the complete analysis for SHSE:600529
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600529 has been successfully added to your 
